Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Kailera Therapeutics, Inc. | 60,000 | reported | 16 Apr 2026 | tx 2+120,000 |
| Translate Bio, Inc. | 60,000 | reported | 08 Mar 2019 | tx 1+60,000 |
| Seres Therapeutics, Inc. | 45,684 | reported | 30 Oct 2023 | tx 8+392,499−12,322 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Apr 2026 | GRANT_AWARD | Kailera Therapeutics, Inc. | 60,000 | 0.00 USD | deriv |
| 16 Apr 2026 | GRANT_AWARD | Kailera Therapeutics, Inc. | 60,000 | 0.00 USD | deriv |
| 27 Oct 2023 | EXERCISE | Seres Therapeutics, Inc. | 9,418 | 0.00 USD | |
| 30 Oct 2023 | SALE | Seres Therapeutics, Inc. | 2,904 | 1.35 USD | |
| 27 Oct 2023 | EXERCISE | Seres Therapeutics, Inc. | 9,418 | 0.00 USD | deriv |
| 27 Apr 2023 | GRANT_AWARD | Seres Therapeutics, Inc. | 18,835 | 0.00 USD | deriv |
| 03 Feb 2023 | GRANT_AWARD | Seres Therapeutics, Inc. | 95,000 | 0.00 USD | deriv |
| 03 Feb 2023 | GRANT_AWARD | Seres Therapeutics, Inc. | 47,500 | 0.00 USD | deriv |
| 05 Jul 2022 | GRANT_AWARD | Seres Therapeutics, Inc. | 31,746 | 3.15 USD | |
| 07 Feb 2022 | GRANT_AWARD | Seres Therapeutics, Inc. | 190,000 | 0.00 USD | deriv |
| 08 Mar 2019 | GRANT_AWARD | Translate Bio, Inc. | 60,000 | 0.00 USD | deriv |